Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. Bd. 96. 2020 S. 431-439
Erscheinungsjahr: 2020
Publikationstyp: Zeitschriftenaufsatz
| Geprüft: | Bibliothek |
Autoren
Zumla, Alimuddin (Autor)
Wang, Fu-Sheng (Autor)
Ippolito, Giuseppe (Autor)
Petrosillo, Nicola (Autor)
Agrati, Chiara (Autor)
Azhar, Esam I. (Autor)
Chang, Chao (Autor)
El-Kafrawy, Sherif A. (Autor)
Osman, Mohamed (Autor)
Zitvogel, Laurence (Autor)
Galle, Peter R. (Autor)
Locatelli, Franco (Autor)
Gorman, Ellen (Autor)
Cordon-Cardo, Carlos (Autor)
O'Kane, Cecilia (Autor)
McAuley, Danny (Autor)
Maeurer, Markus (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
